The immunocytochemical application of a monoclonal antibody (MAb) against the Arg-Arg region at the junction of the C-peptide and the insulin p-chain of the human proinsulin molecule on rat pancreatic tissue resulted in positive immunogold labeling over the insulinas well as the glucagon-seaeting cells. In the insulin cells, the Golgi cisternae and the immature dathrin-ooated granules were k t d y labeled, and in the glucagon cells all the granules were labeled. Control experiments using the ana-proinsulin MAb adsorbed with proinsulin, insulin, and glucagon have confirmed the crossreactivity of this proinsulin andbody with glucagon. Furthermore, the anti-proinsulin MAb appears to crossreact not only with rat but also with human glucagon and with bovine and porcine insulin and glucagon. Examination of the amino acid sequences of proinsulin and
Introduction
The specificity of immunocytochemical results obtained at both the light and the electron microscopic level relies entirely on the properties of the first antibody, independent of the approach employed for the detection. Antibodies raised against a particular well-characterized antigen should be able to bind to this unique antigen and thus to discriminate it from all other proteins. This condition, which is a sine qua non for generating valuable results. has been somewhat challenged by the introduction of monoclonal antibodies (MAbs). Indeed, whereas polydonal antibodies are composed of multiple species of immunoglobulins directed towards several determinants within a particular antigenic molecule, the MAbs are directed against single determinants consisting of very short sequences of amino acids (1) . In this situation, although the MAbs are able to provide invaluable information about the molecular conformation of a particular determinant within that molecule, their use may in certain cases introduce some problems. In fact, although the specificity of the results is not affected, the mul- proglucagon has shown that both molecules dsplay this Arg-Arg dipeptide sequence, which could explain the labeling obtained on both cell types. In addition, other propeptides also display such a sequence and, indeed, positive cells were detected in rat pituitary. These d t s demonstrate that by immunocytochemistry this MAb, although providing very specific results, reveals non-related molecules. This is due to the fact that these molecules exhibit similar short determinants. MAbsraisedagainstwryshortaminoacidsequcnce~ can reveal this determinant in various molecules, generating false-positive results. tiplicity of molecules being recognized by a single MAb could be a problem. This is due to the existence of very similar determinants in various different peptides and proteins.
The aim of the present article is to report such a problem experienced with the use of a very well-characterized MAb directed against a very short determinant. Indeed, a particular MAb recognizing the region of the dipeptide Arg-Arg in the human proinsulin molecule ( 2 ) gives very specific and valid labeling in pancreatic insulin-secreting cells, revealing the sites of proinsulin molecules (3) (4) (5) . However, because same or a similar determinant is also present in other peptides (6,7). the MAb generates positive labeling in other hormone-secreting cells, revealing not proinsulin but rather other non-related peptides. Concem is raised on this potential problem of getting false-positive cytochemical results by the use of certain MAbs.
Materials and Methods
For light microscopy, normal rat pancreatic tissue was fixed in Bouin's fixative and embedded in paraffin. For electron microscopy, human, rat, porcine, and bovine pancreatic tissues, as well as rat pituitary, were fmed by immersion with 1% glutaraldehyde and processed for embedding in Lowicryl sections were mounted on nickel grids and processed for immunocytochemistry using a specific MAb and the protein AIG-gold or IgG-gold complexes.
The anti-human proinsulin MAb (Novo Nordisk BioLabs; Bagwaerd, Denmark) used is directed against the region of the dipeptide Arghrg present at the junction between the C-peptide and the insulin p-chain within the human proinsulin molecule (2,9). It has been characterized by immunochemical and immunocytochemical techniques, having been used for specific demonstration of proinsulin molecules in rat pancreatic insulinsecreting cells (3.4) . The anti-glucagon was a rabbit antiserum ( I N C Stillwater, MN). The protein AIG-gold complex was prepared as reported previously with IO-nm gold particles (10) ; the IgG-gold complex was obtained from British BioCell (Cardiff, UK).
For light microscopic immunostaining. the sections were deparaffinized. rehydrated, and incubated with the MAb (dilution M O ) for 2 hr at room temperature (RT). After rinsing with 0.01 M PBS. they were incubated with a secondary antibody, an anti-mouse IgG tagged with IO-nm gold particles, for 30 min at RT. The sections were further processed for the silver enhancement protocol (11) using the IntenSE M Silver Enhancement kit (Amersham Life Science; Poole, UK).
For electron microscopic immunolabeling. the thin sections were incubated with the same MAb (1:lO dilution) overnight at 4°C. followed by the protein AIG-gold complex for 30 min at RT. Sections were stained with uranyl acetate before examination with a Philips 410SL electron microscope.
Control experiments were performed. Adsorption of the proinsulin MAb with different antigens was carried out before performance of the immunolabeling. Anti-proinsulin was adsorbed with insulin, proinsulin, and glucagon. The tissue sections were incubated with the adsorbed antibody and the protein AIG-gold complex according to the protocol described above.
Results
By light microscopy, on application of the MAb against proinsulin, different cells of the islet of Langerhans in rat pancreas appeared labeled (Figure la) . For the insulin-secreting cells located in the central part of the islet, the staining was not very intense but was concentrated in the Golgi area close to the nuclei. In contrast to this Golgi staining and in addition to the labeling of the insulinsecreting cells, other islet cells, few in number and located at the periphery of the islet, were also labeled and displayed very intense labeling involving the entire cell cytoplasm (Figure la) . On applying the anti-glucagon antibody on a serial section, these same peripheral cells displayed positive labeling, demonstrating that they are in fact glucagon in nature (Figure 1b) .
By electron microscopy on rat pancreatic tissue, the antiproinsulin MAb yielded very specific labeling over the Golgi cisternae and over the light-cored immature secretory granules of the insulin-secreting cells (Figure 2a ). In contrast, the mature insulincontaining granules, having a dense core, were not labeled. In several instances the labeled immature granules appeared delineated by a clathrin-coated membrane (Figure 2 ) as reported previously (3.4) . In addition to labeling of the insulin-secreting cells, the glucagon-secreting cells, characterized by their dark granules having a very narrow clear halo and their peripheral location in the islet, were also labeled, displaying a significant number of gold particles over their secretory granules (Figure 2b ). Somatostatin cells remained unlabeled (not shown). Examination of the amino acid sequences of proinsulin and proglucagon molecules reveals similarities, with the existence of the dipeptide Arg-Arg in both molecules (Figure 3) .
Control experiments using adsorbed anti-proinsulin were car-ried out with different antigens. When the anti-proinsulin was adsorbed with proinsulin, a drastic decrease in labeling intensity was observed in the immature secretory granules of the insulin cells, as well as in the glucagon secretory granules (Figures 4a and 4b) .
When it was adsorbed with insulin, no variation in the labeling pattern was detected in either type of cell (Figures 4c and 4d) . Indeed, the immature secretory granules of the insulin cells and all the secretory granules of the glucagon cells remained intensely labeled. When the antibody was adsorbed with glucagon, a signifi- cant decrease in labeling was noted in the immature secretory granules of the insulin-secreting cells (Figure 4e ), and the glucagon secretory granules were almost free of any labeling (Figure 4f ). Application of the anti-proinsulin antibody on human, porcine, and bovine pancreatic tissues resulted in specific immunolabeling on insulin-and on glucagon-secreting cells (Figure 5 ). For the insulin-secreting cells, labeling was restricted to a few secretory granules, which we assumed to be immature. The poor ultrastructural preservation, particularly on human tissue, did not permit identification of the clathrin coating of these granules. On the other hand, in glucagon-secreting cells most of the granules were labeled with the anti-proinsulin MAb, confirming the results obtained on the rat tissue (Figure 5) . Somatostatin cells remained negative ( Figure Sa) .
Application of the anti-proinsulin MAb on tissue sections of rat pituitary revealed immunogold labeling over some endocrine cells ( Figure 6 ). These cells were characterized by numerous large dark granules which displayed intense labeling. Neighboring cells containing small light granules were devoid of labeling ( Figure 6 ).
Discussion
In the present study we used a very specific and well-characterized MAb raised against a very narrow and definite region in the human proinsulin molecule at the junction between the C-peptide and the insulin B-chain. This area comprises a particular dipeptide, Arg-Arg, which is the target of the convertase PC1 and which participates in the conversion of the proinsulin into C-peptide and insulin (4,7,12). The MAb has been well characterized (2, 9) and has been used in different studies for detection of proinsulin molecules within insulin-secreting cells (3-5). Indeed, confiiing previous reports (3.4). application of this MAb with the immunogold approach on insulin-secreting cells led to labeling restricted to the Golgi cisternae and the immature clathrin-coated secretory granules (Figure 2 ). However, this same MAb gave a very defined and specific labeling over the glucagon-secreting cells, particularly at the level of the secretory granules. Analysis of the amino acid sequence of proinsulin and proglucagon molecules shows that the dipeptide region Arg-Arg is in fact present within both prohormone molecules (Figure 3) . The presence of this determinant in the glucagon molecule could therefore explain the specific and strong labeling found in the glucagon-containing granules, as well as in the results obtained by the control experiments.
By Lnmunochemical techniques, this proinsulin MAb was shown to recognize the Arg-Arg region of the human proinsulin molecule and not to cross-react with bovine or porcine proinsulin (2,9). However, by immunocytochemistry, this same MAb appears not only to react with human proinsulin but also to crossreact with porcine, bovine, and rat proinsulin. In addition, it also binds glucagon molecules in pancreatic cells from all of the above-mentioned species. Moreover, it also appears to recognize some rat pituitary hormones, probably the pro-opiomelanocortin, which displays similar Arg-Arg regions (6) . Although no biochemical test of crossreactivity was performed with other prohormones, the immunochemical techniques have assigned a very narrow specificity to this antibody (23). The wider crossreactivity displayed by this antibody when used with morphological means could be based on the concept proposed (9) that the antibody recognizes not only a very particular amino acid sequence but also the three-dimensional conformation of this determinant. The processing of the tissues for morphological studies, which is known to affect the structure of proteins, may favor particular conformation(s) of similar determinants to resemble the domain present in the parent molecule.
Short amino acid sequences of identical nature can be present in various proteins, and an antibody directed against such a sequence, although still yielding specific labeling, could reveal different molecules not related to the original antigen. This problem, already discussed by Mason et al. (13) and illustrated by the present results, raises the possibility of false-positive labelings with monoclonal antibodies and stresses the care that should be taken before any rapid interpretation of immunocytochemical results.
